Abstract:Objective: To investigate the apoptosis inducing effects of ponicidin (PON) on leukemic K562 cells and its mechanisms of action. Method: K562 cells in culture medium in vitro were given different concentrations of PON (10-50 μmol·L-1) for 24, 48 and 72 h. The inhibitory rate of the cells was measured by MTT assay, cell apoptotic rates were detected by flow cytometry (FCM) by using Annexin V staining after K562 cells were treated with different concentrations of PON for 72 hours, and cell morphology was observed by Wright-Giemsa staining. Western blot was used to detect caspase-3 and poly(ADP-ribose) polymerase (PARP) expression, and the protein levels in mitogen-activated protein kinase signaling pathways (MAPKs, p-P38, p-ERK and p-JNK) as well as p-AKT and p-P85 in PI3K/AKT signaling pathways were also detected. Result: PON (over 30 μmol·L-1) could inhibit the growth of K562 cells in both time- and dose-dependent manner. FCM analysis revealed that apoptotic cells were gradually increased in a dose-dependent manner after treatment for 72 hours, and that marked morphological changes of cell apoptosis such as condensation of chromatin was clearly observed by Wright-Giemsa staining after treatment by 50 μmol·L-1 PON. Western blot showed cleavage of the caspase-3 zymogen protein (32 kD), with the appearance of its 17 kD subunit, and a cleaved 89 kD fragment of 116 kD PARP was also found. Furthermore, Western blotting also showed that expression of p-AKT and p-P85 in PDK/AKT signaling pathways was down-regulated dramatically whereas the expression of p-P38 as well as p-ERK and p-JNK remained unchanged after the cells were treated by PON for 48 h. Conclusion: The results demonstrate that PON exhibits in vitro anti-leukemia effect by induction of apoptosis in K562 cells, and that PON induced apoptosis in K562 cells mainly related to activation of caspase-3 as well as inactivation of PDK/AKT signaling pathway via down regulation of the expression of p-AKT and p-P85 protein levels. These results provide strong laboratory evidence for further anti-leukemia trials of PON.

Anticancer Mechanism of Peptide P18 in Human Leukemia K562 Cells

Effect of Animal Based Hybrid Peptide P18 in Human Leukemia K562 Cell Death

Anti-melanoma Activity of Hybrid Peptide P18 and Its Mechanism of Action

P18: Novel Anticancer Peptide from Induced Tumor-Suppressing Cells Targeting Breast Cancer and Bone Metastasis

NK-18, a Promising Antimicrobial Peptide: Anti-Multidrug Resistant Leukemia Cells and LPS Neutralizing Properties

Effects of a Spiroketal Compound Peniciketal A and Its Molecular Mechanisms on Growth Inhibition in Human Leukemia.

Membrane active antitumor activity of NK-18, a mammalian NK-lysin-derived cationic antimicrobial peptide.

P18 Peptide, a Functional Fragment of Pigment Epithelial-Derived Factor, Inhibits Angiogenesis in Hepatocellular Carcinoma Via Modulating VEGF/VEGFR2 Signalling Pathway.

Beta-aescin: A Potent Natural Inhibitor of Proliferation and Inducer of Apoptosis in Human Chronic Myeloid Leukemia K562 Cells in Vitro

P7 Peptides Suppress the Proliferation of K562 Cells Induced by Basic Fibroblast Growth Factor

The Effect of Cecropin A-Magainin2 Hybrid Antimicrobial Peptide P18 on the MDA-MB-435s Cell Line

Antiproliferation Effects of Ponicidin on Human Myeloid Leukemia Cells in Vitro

Apoptosis inducing effect of ponicidin in leukemia K562 cells and its mechanisms of action

T-18, a Stemonamide Synthetic Intermediate Inhibits Pim Kinase Activity and Induces Cell Apoptosis, Acting As a Potent Anticancer Drug

Anticancer Effects of ZWM233 in Vitro and Its Mechanisms

Puerarin leads to K562 cell apoptosis of chronic myelogenous leukemia via induction of autophagy

Pseudolaric Acid B Triggers Cell Apoptosis by Activating AMPK/JNK/DRP1/mitochondrial Fission Pathway in Hepatocellular Carcinoma

Cytotoxicity of the compounds isolated from Pulsatilla chinensis saponins and apoptosis induced by 23-hydroxybetulinic acid

Engineering Anticancer Amphipathic Peptide-Dendronized Compounds for Highly-Efficient Plasma/Organelle Membrane Perturbation and Multidrug Resistance Reversal

A Litopenaeus vannamei Hemocyanin-Derived Antimicrobial Peptide (Peptide B11) Attenuates Cancer Cells’ Proliferation

Exploration of inhibitors targeting KIF18A with ploidy-specific lethality